GMRS Navigates a Payer Mix Shift and Oil Headwinds, but the Core Story is Scaling Nurse Navigation

GMR Solutions (GMRS), the largest U.S. emergency medical services provider, reported Q2 2026 results that took a step back on the headline EBITDA line but revealed a cleaner, more predictable revenue base going forward. Revenue grew 3.3% to $1.49B, but adjusted EBITDA fell 11.8% to $285M, with a margin of 19.1%. The decline is almost entirely an artifact of last year's one-time collection of No Surprises Act (NSA) claims — the company recognized a $74M swing in IDR process estimate changes year-over-year.

The IDR Tailwind Is Normalizing

CFO Brian Tierney explained the mechanics plainly: “Last year, in the second quarter, we had about $79 million worth of change in estimate related to the No Surprises Act stuff. This year was about $5 million.” While that creates a noisy comp, the company now feels its revenue prediction is far more reliable. “We've been able to really dial in the estimates … we feel that we're going to be more in this 0 plus or minus 5% range here as we go forward.” — Brian Tierney, Executive Vice President and CFO · 2026-08-13 The IDR process remains a central tool for reimbursement, but the company is actively signing more payers in-network — now at ~69% for air — and sees the lower arbitration fees as a slight tailwind.

Payer Mix Shift—A $16M Quarterly Headwind

The expiration of ACA exchange subsidies has begun to bite. Management quantified the impact at roughly $16M per quarter in revenue and EBITDA, with a shift from commercial insurance to self-pay. CEO Nick Loporcaro noted that “geographically, it's different” and that the company is still learning where patients land. The company has levers—subsidy programs and contract pricing—but is holding off until the picture clears. “It's the big exchange providers … we've seen the decrease in their volumes in the states that they were heavy in.” — Brian Tierney, Executive Vice President and CFO · 2026-08-13 This is a headwind that will persist through the back half of 2026, and it is already baked into guidance.

Fuel and Geopolitical Costs Mount

The Iran conflict is directly hitting the P&L. “We've really seen that $10 million plus a quarter really run through the P&L,” Tierney said, and it's not just fuel—airfare, shipping, and even office supply surcharges are inflating costs. The company assumes ~$80/barrel for the rest of the year, with the conflict persisting. This is an industry-wide trend: the global keyword trajectory shows Iran conflict as a top theme across the market, and other recent reporters (e.g., GBF.DE) also cite “Iran war” as a cost driver. GMRS is riding this broader geopolitical wave, though its exposure is modest relative to its scale.

Nurse Navigation: The Differentiator That Keeps Growing

Amid the noise, the operational star remains 911 Nurse Navigation. The program handled nearly 29,000 calls in Q2, up 50% year-over-year, and now covers 29 communities representing 19.7M covered lives. Management sees a path to 100M covered lives over five years, and the platform is already yielding 150 basis points of margin lift in markets where it's deployed. The program is central to new municipal contracts and the rural health transformation initiatives.

World Cup and Other One-Offs

The FIFA World Cup contributed only a couple of million dollars in revenue, a negligible piece. More notable is the company's role as the “safety net” for emergency response, exemplified by its 4th of July deployment of 50 ambulances and 110 personnel to supplement FDNY in New York City. These events reinforce the brand and the integrated model, even if they don't move the financial needle this year.

What This Means for Investors

GMRS is now past the IPO-related stock compensation spike ($129.6M) and the NSA estimate distortion. The core business—emergent ground and air transports—grew volume and NRT (revenue per transport) improved 1.4%. The company reiterated full-year guidance for revenue of $5.89-6.18B and adjusted EBITDA of $1.135-1.195B, while expecting leverage to fall to 3.0x by end-2027. The key risk to watch is whether the ACA subsidy loss is fully offset by in-network contract wins and the continued expansion of higher-margin services like Nurse Navigation.

As the primary provider and connection point to health care facilities and the only nationally integrated air and ground ambulance provider across 46 states and Washington, D.C., we believe GMR is best positioned to capture this demand.

The company's World Cup participation and disaster-response credentials reinforce its brand, but the real story is a cleaner, more predictable reimbursement landscape and a scalable innovation in care navigation. With the market already pricing in many of these factors (the stock has been stable post-IPO), the next few quarters will test whether management can execute on the levers it has identified. For now, the trajectory is constructive, but the margin pressure from fuel and payer mix is real.